Preclinical mechanistic study in cell and animal models demonstrating a potential strategy; no clinical trial data, human efficacy evidence, or comparison to standard care reported.
This is a preclinical mechanistic study of a novel nanoparticle in an experimental system; it demonstrates proof-of-concept but lacks clinical translation, human data, or controlled comparison to standard therapy.
This is a narrative review synthesizing preclinical and mechanistic evidence on an emerging material platform; it raises questions about clinical potential rather than answering them with clinical trial data.
First-in-vivo preclinical study of a novel PSMA-targeted nanobubble contrast agent in an orthotopic rabbit model, demonstrating proof-of-concept with exploratory endpoints constrained by small cohort size and non-specific histologic validation.
This is a comprehensive review article synthesizing current knowledge on biomaterial-based extracellular vesicle delivery systems for wound healing, presenting fabrication strategies, release mechanisms, and applications rather than reporting primary experimental evidence.
This is a mechanistic study using engineered nanomaterials and cell models to propose a novel repair pathway; it raises questions about stress granule exhaustion in infection rather than answering them with clinical or in vivo efficacy data.
Sound mechanistic study in aged mice using genetic models and a novel hydrogel intervention showing accelerated fracture healing, but limited to preclinical animal work without human efficacy data or clinical trial evidence.
Early-stage in vivo validation of a novel nanocomposite hydrogel in a murine periodontitis model with no clinical data, comparative controls, or quantified efficacy metrics reported.